CardioVascular and Interventional Radiology最新文献

筛选
英文 中文
Transfemoral-Transcaval Liver Biopsy (TFTC) and Transjugular Liver Biopsy (TJLB) in Patients with Fontan-Associated Liver Disease (FALD). 丰坦相关性肝病 (FALD) 患者的经口-经腔肝活检 (TFTC) 和经颈静脉肝活检 (TJLB)。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-05-30 DOI: 10.1007/s00270-024-03761-6
Muhammad Usman Shahid, Yosef Frenkel, Norbert Kuc, Yosef Golowa, Jacob Cynamon
{"title":"Transfemoral-Transcaval Liver Biopsy (TFTC) and Transjugular Liver Biopsy (TJLB) in Patients with Fontan-Associated Liver Disease (FALD).","authors":"Muhammad Usman Shahid, Yosef Frenkel, Norbert Kuc, Yosef Golowa, Jacob Cynamon","doi":"10.1007/s00270-024-03761-6","DOIUrl":"10.1007/s00270-024-03761-6","url":null,"abstract":"<p><strong>Purpose: </strong>To describe our experience in performing transfemoral-transcaval liver biopsy (TFTC) and transjugular liver biopsy (TJLB) in patients with Fontan-associated liver disease (FALD).</p><p><strong>Methods: </strong>A single-center, retrospective review of 23 TFTC and seven TJLB performed between August 2011 and May 2023 on patients who previously underwent the Fontan procedure (median age 23.1 years, ranging 11-43 years, 48% female). Patient demographics, laboratory values, pathology, radiology, and cardiology reports were reviewed. Liver explants were correlated with histopathological evaluation to determine sampling accuracy when available.</p><p><strong>Results: </strong>All biopsies achieved technical success (accurate targeting and safe tissue sample extraction) and histopathological success (yielding sufficient tissue for accurate diagnosis). Liver biopsies were performed during simultaneous cardiac catheterization in 28 of 30 (93%) procedures. There was no statistically significant change in hemoglobin, hematocrit, platelet count post-procedure, and fluoroscopy times. There was one major complication within the TJLB group and one minor complication within the TFTC group.</p><p><strong>Conclusion: </strong>Transvenous liver biopsies, whether via transfemoral or transjugular route, may be safely performed in FALD patients while yielding samples with technical and histopathological success. The transfemoral approach, which is our preferred method; its compatibility with simultaneous cardiac catheterization and its potentially increased safety profile stemming from the avoidance of transversing the Fontan shunt-makes it a particular advantageous option in the management of FALD.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11239768/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141178829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound Contrast Agent Needle Priming: Impact on Sonographic Biopsy Needle Visibility in a Porcine Liver Model. 超声造影剂针引流:猪肝脏模型中超声活检针可见度的影响。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-06-19 DOI: 10.1007/s00270-024-03758-1
Per Thunswärd, Ellen Bergkvist, Liya Vishnevskaya, Yngve Forslin, Håkan Ahlström
{"title":"Ultrasound Contrast Agent Needle Priming: Impact on Sonographic Biopsy Needle Visibility in a Porcine Liver Model.","authors":"Per Thunswärd, Ellen Bergkvist, Liya Vishnevskaya, Yngve Forslin, Håkan Ahlström","doi":"10.1007/s00270-024-03758-1","DOIUrl":"10.1007/s00270-024-03758-1","url":null,"abstract":"<p><strong>Purpose: </strong>The visibility of biopsy needles in contrast-specific imaging mode can be improved by priming them with an ultrasound contrast agent (previously demonstrated in a phantom model/ex vivo). The purpose of this study was to validate this priming method in a porcine in vivo model.</p><p><strong>Materials and methods: </strong>Using a small syringe, full-core biopsy needles were primed with sulfur hexafluoride, an ultrasound contrast agent, with non-primed needles serving as controls (n = 30 + 30). Liver punctures were performed in a porcine model following intravenous administration of the same ultrasound contrast agent. Needle visibility, both in their entirety and at the tips, was evaluated in split-screen mode using contrast-specific imaging and B-mode (low mechanical index). The assessment included quantitative analysis, calculating the contrast-to-noise ratio, and qualitative evaluation through structured grading by three radiologists.</p><p><strong>Results: </strong>After needle priming, the contrast-to-noise ratio was superior for the needle in its entirety in contrast-specific imaging mode (p < 0.001) and slightly inferior in B-mode (p = 0.008). No differences were observed for the needle tips in either imaging mode. Qualitatively, the needle visibility was deemed clinically superior after needle priming throughout in contrast-specific imaging mode (p < 0.001), whereas no clinically relevant differences in B-mode for either the needle in its entirety (p = 0.11) or the needle tip (p = 1) were observed.</p><p><strong>Conclusion: </strong>In this in vivo porcine liver model experiment, priming biopsy needles with ultrasound contrast agent improved needle visibility in contrast-specific imaging mode but slightly reduced it in B-mode. These findings support the method's use for biopsies requiring target visualization in contrast-specific imaging mode.</p><p><strong>No level of evidence: </strong></p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11239778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141426377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluoroscopy-guided Urethral Catheter Insertion with Guidewire and Catheter for Complex Male Urinary Catheterizations by Interventional Radiologists. 介入放射科医生在荧光镜引导下使用导丝和导管插入尿道导管,进行复杂的男性导尿术。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-05-15 DOI: 10.1007/s00270-024-03737-6
Atsushi Saiga, Takeshi Aramaki, Rui Sato, Kazuhisa Asahara
{"title":"Fluoroscopy-guided Urethral Catheter Insertion with Guidewire and Catheter for Complex Male Urinary Catheterizations by Interventional Radiologists.","authors":"Atsushi Saiga, Takeshi Aramaki, Rui Sato, Kazuhisa Asahara","doi":"10.1007/s00270-024-03737-6","DOIUrl":"10.1007/s00270-024-03737-6","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140944028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Catheter Method in Sclerotherapy in the Management of Ovarian Endometriomas. 治疗卵巢子宫内膜异位症的硬化疗法中的导管法。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-06-17 DOI: 10.1007/s00270-024-03775-0
Jörg Keckstein, Simon Keckstein
{"title":"The Catheter Method in Sclerotherapy in the Management of Ovarian Endometriomas.","authors":"Jörg Keckstein, Simon Keckstein","doi":"10.1007/s00270-024-03775-0","DOIUrl":"10.1007/s00270-024-03775-0","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141417961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on "Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness". 关于 "利用全肝磁共振成像放射组学预测TACE难治性肝细胞癌患者的生存期 "的评论文章
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-06-24 DOI: 10.1007/s00270-024-03794-x
Arash Najafi
{"title":"Commentary on \"Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness\".","authors":"Arash Najafi","doi":"10.1007/s00270-024-03794-x","DOIUrl":"10.1007/s00270-024-03794-x","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141445703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remembering the Important and Complimentary Place of Both Interventional Radiologists and Hepatobiliary Surgeons in the Hepatocellular Carcinoma (HCC) Multidisciplinary Team. 牢记介入放射医师和肝胆外科医生在肝细胞癌 (HCC) 多学科团队中的重要和互补地位。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-05-16 DOI: 10.1007/s00270-024-03751-8
Warren Clements, Nicholas Brown, Jim Koukounaras
{"title":"Remembering the Important and Complimentary Place of Both Interventional Radiologists and Hepatobiliary Surgeons in the Hepatocellular Carcinoma (HCC) Multidisciplinary Team.","authors":"Warren Clements, Nicholas Brown, Jim Koukounaras","doi":"10.1007/s00270-024-03751-8","DOIUrl":"10.1007/s00270-024-03751-8","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140956598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re-expansion Pulmonary Edema (REPE) Following Thoracentesis: Is Large-Volume Thoracentesis Associated with Increased Incidence of REPE? 胸腔穿刺术后再膨胀性肺水肿 (REPE):大容量胸腔穿刺术与 REPE 发生率增加有关吗?
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-06-10 DOI: 10.1007/s00270-024-03773-2
Sandon Scott, Brennan Morrison, Kate Young, Lauren Clark, Yanming Li, Carissa Walter, Aaron Rohr, Adam Alli
{"title":"Re-expansion Pulmonary Edema (REPE) Following Thoracentesis: Is Large-Volume Thoracentesis Associated with Increased Incidence of REPE?","authors":"Sandon Scott, Brennan Morrison, Kate Young, Lauren Clark, Yanming Li, Carissa Walter, Aaron Rohr, Adam Alli","doi":"10.1007/s00270-024-03773-2","DOIUrl":"10.1007/s00270-024-03773-2","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the safety and efficacy associated with drainage volumes greater than 1,500 mL in a single, unilateral thoracentesis without pleural manometry measurements.</p><p><strong>Materials and methods: </strong>This retrospective, single-institution study included 872 patients (18 years and older) who underwent ultrasound-guided thoracentesis. Patient and procedures data were collected including demographics, number of and laterality of thoracenteses, volume and consistency of fluid removed, and whether clinical or radiologic evidence of re-expansion pulmonary edema (REPE) developed within 24 h of thoracentesis. Fisher's exact test was used to test the significance of the relationship between volume of fluid removed and evidence of REPE.</p><p><strong>Results: </strong>A total of 1376 thoracenteses were performed among the patients included in the study. The mean volume of fluid removed among all procedures was 901.1 mL (SD = 641.7 mL), with 194 (14.1%) procedures involving the removal of ≥ 1,500 mL of fluid. In total, six (0.7%) patients developed signs of REPE following thoracentesis, five of which were a first-time thoracentesis. No statistically significant difference in incidence of REPE was observed between those with ≥ 1,500 mL of fluid removed compared to those with < 1,500 mL of fluid removed (p-value = 0.599).</p><p><strong>Conclusions: </strong>Large-volume thoracentesis may safely improve patients' symptoms while preventing the need for repeat procedures.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Perfect Fit: Unraveling the Treatment Algorithms for Symptomatic Hepatic Hemangiomas. 完美契合:解读有症状肝血管瘤的治疗方案。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-06-18 DOI: 10.1007/s00270-024-03749-2
Shamar Young, Jafar Golzarian
{"title":"The Perfect Fit: Unraveling the Treatment Algorithms for Symptomatic Hepatic Hemangiomas.","authors":"Shamar Young, Jafar Golzarian","doi":"10.1007/s00270-024-03749-2","DOIUrl":"10.1007/s00270-024-03749-2","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141417962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethanol Sclerotherapy in the Management of Ovarian Endometrioma: Technical Considerations for Catheter- and Needle-Directed Sclerotherapy. 乙醇硬化疗法治疗卵巢子宫内膜异位症:导管和针导硬化疗法的技术考虑因素。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-03-29 DOI: 10.1007/s00270-024-03694-0
Aynur Azizova, Turkmen Turan Ciftci, Murat Gultekin, Emre Unal, Okan Akhan, Gurkan Bozdag, Devrim Akinci
{"title":"Ethanol Sclerotherapy in the Management of Ovarian Endometrioma: Technical Considerations for Catheter- and Needle-Directed Sclerotherapy.","authors":"Aynur Azizova, Turkmen Turan Ciftci, Murat Gultekin, Emre Unal, Okan Akhan, Gurkan Bozdag, Devrim Akinci","doi":"10.1007/s00270-024-03694-0","DOIUrl":"10.1007/s00270-024-03694-0","url":null,"abstract":"<p><strong>Purpose: </strong>To provide technical guidance on applying catheter-directed and needle-directed ethanol sclerotherapy for endometriomas and present the results of these sclerotherapy methods.</p><p><strong>Materials and methods: </strong>From January 2015 to March 2021, the results of the patients with symptomatic ovarian endometriomas who underwent needle-directed or catheter-directed sclerotherapy were evaluated, retrospectively. The decision to apply which sclerotherapy technique was made during the procedure for each patient considering the following factors: cyst size, cyst location, cyst viscosity, and tissue rigidity.</p><p><strong>Results: </strong>Both needle-directed (n = 34 cysts) and catheter-directed (n = 34 cysts) sclerotherapy techniques were effective, with a 100% technical success rate and a 97% clinical success rate. In two of 34 cysts (6%) treated with needle-directed sclerotherapy, recurrence was detected and successfully retreated with catheter-directed sclerotherapy. Significant reductions in cyst size, pain, and serum cancer antigen 125 levels (p < 0.05) were noted. Serum anti-Müllerian hormone levels remained unaffected, indicating preserved ovarian reserve (p > 0.05). Among those treated for infertility, the pregnancy rate was 54% (n = 6/11). The mean ± SD cyst size decline was greater in catheter-directed sclerotherapy than needle-directed sclerotherapy (5.5 ± 3.1 cm vs. 4.0 ± 2.1 cm, p < 0.05). However, the pretreatment cyst volumes were considerably higher in catheter-directed sclerotherapy group (202.0 ± 233.5 mL vs. 78.8 ± 59.7 mL, p < 0.05) and were associated with significant post-treatment volume decrease (p < 0.05).</p><p><strong>Conclusion: </strong>The choice between catheter-directed and needle-directed ethanol sclerotherapy should be determined during the procedure, with a preference for catheter-directed sclerotherapy when feasible. Crucial factors in making this decision include cyst size, cyst location, cyst viscosity, and tissue rigidity. Level of evidence Level 3, non-controlled retrospective cohort study.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11239738/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140326370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility of Sirolimus Eluting Balloons in the Setting of Chronic Limb Threatening Ischaemia in Asian Patients from Singapore - 12 Months Results of the PRISTINE Registry. 西罗莫司洗脱球囊在新加坡亚洲慢性肢体缺血患者中的应用--PRISTINE 登记 12 个月的结果。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2024-07-01 Epub Date: 2024-06-19 DOI: 10.1007/s00270-024-03756-3
T Y Tang, C Yap, S L Chan, S X Y Soon, C Sivanathan, A Gogna, A K Patel, T T Chong
{"title":"The Utility of Sirolimus Eluting Balloons in the Setting of Chronic Limb Threatening Ischaemia in Asian Patients from Singapore - 12 Months Results of the PRISTINE Registry.","authors":"T Y Tang, C Yap, S L Chan, S X Y Soon, C Sivanathan, A Gogna, A K Patel, T T Chong","doi":"10.1007/s00270-024-03756-3","DOIUrl":"10.1007/s00270-024-03756-3","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of PRISTINE was to evaluate the 6 and 12 months safety and efficacy of the Selution Sustained Limus Release (SLR)™ sirolimus-coated balloon for treatment of complex lower limb occlusive lesions (TASC II C & D) in patients with chronic limb threatening ischemia (CLTI) from Singapore.</p><p><strong>Methods: </strong>PRISTINE was a prospective, non-randomized, single arm, observational, multi-investigator, single-center clinical study. Complication-free survival at 30 days was the safety clinical endpoint. Immediate technical success (ability to cross and dilate the lesion and achieve residual angiographic stenosis < 30%), 6-month primary vessel patency, limb salvage, clinically driven target lesion revascularization (TLR) and amputation free survival (AFS) were the efficacy endpoints of interest.</p><p><strong>Results: </strong>Seventy five patients were included. There were 50 (68.0%) males; mean age, 69.0 ± 10.7 years. CLTI severity was based on the Rutherford Scale (R5 = 51; R6 = 17). Significant co-morbidities included diabetes mellitus (n = 68; 91.0%) and end-stage renal failure (n = 28; 37.0%). 112 atherosclerotic lesions were treated (TASC II D = 58 (52%); 76 (67%) de novo). There was 100% technical success. Mean lesion length treated was 22.4 ± 13.9 cm. Primary vessel patencies at 6 and 12 months were 64/86 (74%) and 43/74 (58%) and freedom from clinically driven TLR were 72/86 (84%) and 55/74 (74%) respectively. AFS was 61/73 (84.0%; five deaths and seven major lower extremity amputation) at 6-months. Mean Rutherford score improved from 5.1 ± 0.55 at baseline to 1.1 ± 2.05 (p < 0.05) at one year and there was a wound healing rate of 38/48 (79%) at the same timepoint.</p><p><strong>Conclusions: </strong>The Selution SLR™ drug eluting balloon is safe and efficacious in treating highly complex infra-inguinal atherosclerotic lesions in an otherwise challenging frail population of CLTI patients with a high incidence of diabetes and end-stage renal failure. It is associated with highly satisfactory acute technical and clinical success, 12-month target lesion patency and AFS.</p><p><strong>Level of evidence: </strong>Level 2b, Individual Cohort Study.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11239725/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141426376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信